The International Conference on Ophthalmology & Vision Science is going to be held on May 25-26, 2023 in London, UK. This conference unites a one-of-a-kind and worldwide blend of substantial and medium pharmaceutical, biotech, and symptomatic or diagnostic organizations, leading universities, and clinical research companies making the meeting an ideal stage to share understanding, encourage coordinated efforts crosswise over industry and the scholarly community and assess rising advancements over the globe. The theme of the current year's meeting is Advance techniques and modern trends in the field of ophthalmology. Meet noteworthy Ophthalmologists, Optometrists Researchers, and Clinicians from the United Kingdom, The United States of America, Rome, Japan, Germany, Switzerland, Ireland, Russia, Singapore, Dubai, Saudi Arabia, China, Turkey, Spain, Taiwan, Chicago, Korea, India, Australia, and many more nations.

Objective:

We aim to provide cataract surgeons, refractive surgeons, optometrists, opticians, young researchers, students, industrial delegates, and anyone professionally involved in the study of cataract and refractive surgery with an opportunity to learn about the complexity of the disease, discuss interventional procedures, look at new and advanced cataract removal practices and their efficiency and efficacy in the treatment of various refractive errors and cataract extraction, and understand local realities and practical constraints in improving vision-care.

Our Vision:

"We aim to bring the research and innovations happening around the world to facilitate interaction, knowledge sharing, and exchange." We also hope to inspire university professors, students, researchers, clinicians, and entrepreneurs from a variety of fields, including but not limited to clinical, medical, business, technology, healthcare, and pharmaceutical. Through scientific gatherings and deliberations, we hope to bring advancements in science and technology to humanity. We believe in introducing novel methods and techniques in science, business, and technology to provide a better understanding of the developments."

Benefits of Attending our Conference:                  

• Get publication of your abstract with DOI
• Young Scientist Award recognition certificate and memento to the winners
• Be acquainted with the modern-day improvements and demanding situations inside your industry
• Our conferences provide best Platform for your research through oral presentations.
• Learn about career improvement with all the latest technologies.
• Young Scientists will get appropriate and timely information by this Forum.
• Platform for collaboration among young researchers for better development.
• Provide an opportunity for research interaction and established senior investigators across the globe in the field of Diabetes
• Share the ideas with both eminent researchers and mentors.
• It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge and increase participation
• Great resource for learning new career skill

Market Analysis : 

Global market research of ophthalmology

Ophthalmology is expected to reach $$71.9 billion by 2025 from $11.81 Billion in 2021 at a CAGR of 4.8 %. Ophthalmology is a field that deals with the medical treatment of Vision, children, and adolescents. Region/country wise Ophthalmology market report is available at Ophthalmology 2023

The global ophthalmology market witnessed a dip during the economic downturn in 2008 and 2009; however, it is poised to grow at a stable rate mainly due to an increasing aging population, large pool of patients with eye diseases, changing demographics and geographical trends, and increased focus on combination therapies of drugs. Moreover, incidences of glaucoma and cataract are increasing every year.

Cataract is responsible for 48% of the population becoming totally blind. In addition, more than 60 million people suffer from glaucoma and this number is expected to reach 80 million by 2020. An increasing aging population is also resulting in more people suffering from refractive errors. It is estimated that in the U.S. and Europe, refractive errors affect more than 30% of the population aged 40 or older. However, the economic slowdown and drying pipeline of ophthalmology drugs is restricting the market.

Scope of the Report:

The research report categorizes the global ophthalmology drugs and devices market into diagnostic devices, surgical devices, vision care and drugs.  All these markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the devices market is comprehensively analysed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario. However, the drugs market is analysed in the U.S., Europe, Japan, Asia, and Rest of the world.

According to WHO:

• 285 million people are estimated to be visually impaired worldwide: 39 million are blind and 246 have low vision.
• About 90% of the world’s visually impaired live in low-income settings.
• 82% of people living with blindness are aged 50 and above.
• Globally, uncorrected refractive errors are the main cause of moderate and severe visual impairment; cataracts remain the leading cause of blindness in middle- and low-income countries.
• The number of people visually impaired from infectious diseases has reduced in the last 20 years according to global estimates work.
• 80% of all visual impairment can be prevented or cured.
• Cataract removal is the most commonly performed ophthalmic surgical operation
• Ophthalmic Drugs & Devices – Market Analysis

The Global Ophthalmic Device Market is poised to grow at a CAGR of around 4.8% over the next decade to reach approximately $71.9 billion by 2025. According to a new market report published by Transparency Market Research "Ophthalmology Diagnostics and Surgical Devices Market (Optical Coherence Tomography, Echography, Corneal Topographers, Specular Microscopes, Cataract, Refractive, Glaucoma and Vitreous retinal Surgery Devices)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global Ophthalmology Devices market was valued at USD26,012.6million in 2012 and estimated to reach a market worth USD40,381.6 million in 2019 at a CAGR of 6.6 % from 2013 to 2019. Asia Pacific ophthalmic drugs & devices market was valued at $11815.02 million in 2016 and is expected to reach $20920.43 million by 2025 growing at a CAGR of 6.64% during the forecast period of 2017-2025.

Event summary

Conferences are an active forum for academic researchers and business leaders. It involves multiple presentations, interactive breakout meetings, hands-on product demonstrations, and unrivaled networking opportunities. We have invited some of the world's most desirable keynote speakers, Brand ambassadors, Experts, and industry leaders to share their thoughts and ideas with our conference guests.